Penserra Capital Management LLC Orchard Therapeutics PLC Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$1.16 - $2.23 $1,954 - $3,757	-1,685 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.24 - $4.29 $369 - $707	165 Added 10.86%	1,685 $3,000
Q2 2021 Aug 12, 2021	BUY	$4.39 - $7.23 $570 - $939	130 Added 9.35%	1,520 $6,000
Q1 2021 May 13, 2021	SELL	$4.39 - $9.08 $21 - $45	-5 Reduced 0.36%	1,390 $10,000
Q4 2020 Feb 12, 2021	BUY	$3.86 - $5.07 $3,400 - $4,466	881 Added 171.4%	1,395 $6,000
Q3 2020 Nov 13, 2020	BUY	$4.11 - $6.45 $2,112 - $3,315	514 New	514 $2,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.